Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis

Clinical trial NCT00037102 · COMPLETED

Trial details

NCT number: NCT00037102
Sponsor: MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2001-07-01
Primary completion: 2003-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.